Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.

Deepika SureshAshley LiMatthew J MillerKarn Wijarnpreecha Vincent L Chen

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

In MASLD patients, metabolic hyperferritinaemia was associated with increased mortality and higher incidence of liver-related events, and cirrhosis-promoting alleles but not with iron overload-promoting HFE mutations.

Keyphrases

end stage renal disease
ejection fraction
risk factors
newly diagnosed
prognostic factors
type diabetes
cardiovascular disease
patient reported